Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ELOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 63.39M
March 31, 2026 8.503M
June 30, 2025
September 30, 2023 6.042M
June 30, 2023 5.993M
March 31, 2023 7.20M
December 31, 2022 21.12M
September 30, 2022 26.88M
June 30, 2022 32.94M
March 31, 2022 43.62M
December 31, 2021 45.14M
September 30, 2021 55.38M
June 30, 2021 60.61M
March 31, 2021 20.37M
December 31, 2020 26.48M
September 30, 2020 32.94M
June 30, 2020 39.92M
March 31, 2020 47.04M
December 31, 2019 58.95M
September 30, 2019 68.06M
June 30, 2019 79.04M
March 31, 2019 56.89M
December 31, 2018 50.72M
September 30, 2018 56.54M
June 30, 2018 64.27M
Date Value
March 31, 2018 19.16M
June 30, 2017 5.845M
March 31, 2017 5.842M
December 31, 2016 5.807M
September 30, 2016 7.013M
June 30, 2016 9.226M
March 31, 2016 10.56M
December 31, 2015 15.64M
September 30, 2015 19.44M
June 30, 2015 19.55M
March 31, 2015 16.92M
December 31, 2014 18.55M
September 30, 2014 28.14M
June 30, 2014 33.33M
March 31, 2014 10.96M
December 31, 2013 11.10M
September 30, 2013 5.815M
June 30, 2013 7.098M
March 31, 2013 6.892M
December 31, 2012 5.464M
September 30, 2012 6.260M
June 30, 2012 6.955M
March 31, 2012 8.635M
December 31, 2011 6.857M
September 30, 2011 8.272M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 103.90M
CorMedix, Inc. 904.05M
Cannabis Global, Inc. 0.885M
Breakthrough Chemistry, Inc. 1.300M
BioStem Technologies, Inc. 48.82M

Total Assets (Quarterly) Related Metrics